Abstract Purpose This study investigates the risk of contrast-associated acute kidney injury (CA-AKI) in trauma patients, focusing on the impact of cumulative contrast medium doses. Methods A retrospective review was conducted at a level 1 trauma center (2019–2021). The study included patients who underwent intravascular contrast-enhanced (Omnipaque 350 mg I/ml) examinations for torso trauma within 7 days post-injury. The total contrast medium volume within 7 days was calculated. AKI was defined using the KDIGO grading system based on creatinine data. Multivariate logistic regression (MLR) identified AKI risk factors. Results Among the 264 patients, 7.2% (19/264) developed AKI, with 3.4% (9/264) classified as KDIGO stage 3. Approximately 42.8% of patients underwent at least two contrast-enhanced examinations. The mean total contrast medium given was 129.5mL (range 80-410ml). Multiple logistic regression (MLR) analysis identified four independent risk factors for AKI: diabetes mellitus, initial eGFR < 30, use of inotropic agents, and contrast medium exposure. The odds ratio of AKI increased by 2.92 (95% CI 1.30–6.53) for every 100ml increase in contrast dose. And the contrast volume exposure only plays important role in severe trauma patients (ISS ≥ 25). Moreover, when correlated with eGFR, the contrast medium exposure volume demonstrated better predictive ability for AKI, with a best cut-off value of Contrast volume to eGFR ratio > 1.86. Conclusion While repetitive contrast-enhanced examinations are sometimes inevitable, it does come with costs. The CA-AKI risk increases as the amount of contrast medium accumulates in trauma patients who requires repetitive examinations.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: